NCT06421649View on ClinicalTrials.gov

Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2029

Conditions
Parotid Cancer
Interventions
RADIATION

Proton Beam Therapy

All patients will be offered radical adjuvant proton beam therapy to a dose of 60-66 Gray (Gy) in 30-33 fractions delivered Monday to Friday over 6-6.5 weeks.

All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

collaborator

University College London Hospitals

OTHER

lead

The Christie NHS Foundation Trust

OTHER

NCT06421649 - Investigating the Role of Adjuvant Proton Beam Therapy in Patients With Parotid Carcinoma | Biotech Hunter | Biotech Hunter